Trial intelligence / Profile preview

Evarrest vs Standard of Care for Severe Soft Tissue Bleeding

NCT00977925Phase 3Completed

Sponsor
Ethicon
Start
Aug 2009
Primary completion
Jan 2011
Modality
Recombinant Proteins and Enzymes
Countries
4
01

Overview

A Phase 3 trial of Fibrinogen human, sponsored by Ethicon. Started Aug 2009; status: completed.

02

Drugs

Fibrinogen human

Beyond the preview

Go deeper on NCT00977925.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00977925.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call